NMNAT1 and neuroblastoma: The prognostic effects of BCAR3, CLSTN1, CTNNBIP1, DNAJC8, HMGCL, NMNAT1, PANK4, PHF13, STX12, UBE2J2 and ZNF436 in neuroblastoma patients were further validated using TARGET, GSE16476, GSE62564 and GSE85047 datasets.